Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
Merck
Baxter
US Army
Cipla
UBS
Queensland Health
Mallinckrodt
Citi

Generated: October 24, 2017

DrugPatentWatch Database Preview

Drug Master Files for: mesalamine

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
8070AII5/9/1989PHARMAZELL GMBH5-AMINOSALICYLIC ACID (MESALAZINE/MESALAMINE)
9562III11/22/1991INTERFALK CANADA INCSALOFALK 250MG MESALAMINE ENTERIC COATED TABLETS
11807AII1/15/1996CORDEN PHARMA BERGAMO SPAMESALAMINE
11951AII4/29/1996CHEMI SPAMESALAMINE USP
13883AII12/3/1998ERREGIERRE SPAMESALAMINE USP-EP
16431III2/17/2003SUN PHARMACEUTICAL INDUSTRIES LTDMESALAMINE USP (5-AMINO SALICYLIC ACID)
18054III2/2/2005SIMS SRLMESALAMINE
18387III5/27/2005DR REDDYS LABORATORIES LTDMESALAMINE
18742AII9/9/2005INFAR SA5-AMINOSALICYLIC ACID I (MESALAMINE)
19261AII4/18/2006IPCA LABORATORIES LTDMESALAMINE USP
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Dow
Cipla
QuintilesIMS
Medtronic
Johnson and Johnson
McKinsey
Novartis
Baxter
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot